[Isoniazid pharmacokinetics in the combined chemotherapy of tuberculosis]. 1981

G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D007700 Kinetics The rate dynamics in chemical or physical systems.
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia
September 1953, American review of tuberculosis,
G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia
February 1990, Indian pediatrics,
G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia
January 1985, Sovetskaia meditsina,
G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia
November 1958, Revista brasileira de tuberculose e doencas toracicas,
G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia
August 1958, La Riforma medica,
G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia
May 1961, Kekkaku : [Tuberculosis],
G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia
June 2005, Archives of disease in childhood,
G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia
March 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia
March 1957, Minerva medica,
G B Sokolova, and R N Vilenskaia, and A Ia Ivleva, and N N Galenko, and A V Ziia
February 1955, British medical journal,
Copied contents to your clipboard!